APA (7th ed.) Citation

Hajikarimloo, B., Habibi, M. A., Kooshki, A., Alvani, M. S., Zare, A. H., Hasanzade, A., . . . Tos, S. M. (2024). Dabrafenib plus trametinib in low-grade versus high-grade gliomas. BMC Cancer, 24(1), . https://doi.org/10.1186/s12885-024-13229-y

Chicago Style (17th ed.) Citation

Hajikarimloo, Bardia, et al. "Dabrafenib Plus Trametinib in Low-grade Versus High-grade Gliomas." BMC Cancer 24, no. 1 (2024). https://doi.org/10.1186/s12885-024-13229-y.

MLA (9th ed.) Citation

Hajikarimloo, Bardia, et al. "Dabrafenib Plus Trametinib in Low-grade Versus High-grade Gliomas." BMC Cancer, vol. 24, no. 1, 2024, https://doi.org/10.1186/s12885-024-13229-y.